AU2393992A - Combination therapy using bioflavonoid compounds with anti-cancer drugs - Google Patents
Combination therapy using bioflavonoid compounds with anti-cancer drugsInfo
- Publication number
- AU2393992A AU2393992A AU23939/92A AU2393992A AU2393992A AU 2393992 A AU2393992 A AU 2393992A AU 23939/92 A AU23939/92 A AU 23939/92A AU 2393992 A AU2393992 A AU 2393992A AU 2393992 A AU2393992 A AU 2393992A
- Authority
- AU
- Australia
- Prior art keywords
- combination therapy
- cancer drugs
- bioflavonoid compounds
- bioflavonoid
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73804491A | 1991-07-24 | 1991-07-24 | |
US738044 | 1996-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2393992A true AU2393992A (en) | 1993-02-23 |
Family
ID=24966338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU23939/92A Abandoned AU2393992A (en) | 1991-07-24 | 1992-07-17 | Combination therapy using bioflavonoid compounds with anti-cancer drugs |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2393992A (fr) |
WO (1) | WO1993001824A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1271301B (it) * | 1994-12-20 | 1997-05-27 | Indena Spa | Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono |
WO2005016864A1 (fr) | 2003-07-29 | 2005-02-24 | The Arizona Disease Control Research Commission | Agents anticancereux a base de nitro-alcene conjugue utilisant le metabolisme des isoprenoides |
WO2005077405A1 (fr) * | 2004-02-06 | 2005-08-25 | Cancer Treatment International | Compositions et methodes de traitement du cancer par elevation systemique de lactate et depletion d'arginine |
US8815232B2 (en) | 2008-08-26 | 2014-08-26 | Kyon Biotech Ag | Compositions and methods for treating cancer |
TW201036624A (en) * | 2009-03-27 | 2010-10-16 | Biotropics Malaysia Berhad | Aurones as selective PDE inhibitors and their use in neurological conditions and disorders |
TW201036608A (en) * | 2009-03-27 | 2010-10-16 | Biotropics Malaysia Berhad | Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases |
US9884825B2 (en) | 2012-08-03 | 2018-02-06 | Georgia State University Research Foundation, Inc. | Curcumin analogs and methods of making and using thereof |
WO2017180644A1 (fr) | 2016-04-11 | 2017-10-19 | Middle Tennessee State University | Aurones thérapeutiques |
KR102609490B1 (ko) * | 2020-09-01 | 2023-12-04 | 부산대학교 산학협력단 | Pak1 억제활성을 갖는 신규 화합물 및 이의 용도 |
-
1992
- 1992-07-17 AU AU23939/92A patent/AU2393992A/en not_active Abandoned
- 1992-07-17 WO PCT/US1992/006087 patent/WO1993001824A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1993001824A1 (fr) | 1993-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4227793A (en) | Drug infuser | |
AU2263692A (en) | Multiple pharmaceutical syringe | |
AU3891889A (en) | Cardioplegia administration set | |
AU2080992A (en) | Iv administration set infiltration monitor | |
AU2087992A (en) | Pharmaceutical combination formulation | |
AU3888793A (en) | Novel medicament | |
AU7320394A (en) | Pro-cytotoxic drug conjugates for anticancer therapy | |
GB9121204D0 (en) | Medicament | |
GB9410236D0 (en) | Cytotoxic drug therapy | |
AU3313889A (en) | Novel unit dosage form | |
AU1330392A (en) | Safety syringe | |
AU3225993A (en) | Patient controlled bolus dosage infuser | |
AU4377793A (en) | Alternative receptor therapy | |
AU2657192A (en) | Simplified security syringe | |
AU2393992A (en) | Combination therapy using bioflavonoid compounds with anti-cancer drugs | |
GB9121463D0 (en) | Medicament | |
AU663106B2 (en) | Porphyrin-based anti-HIV drug | |
AU662160B2 (en) | Analgesic | |
AU8614291A (en) | Device for administering drugs | |
AU2493792A (en) | Pharmaceutical preparation | |
AU1740692A (en) | New medicinal use | |
AU1065088A (en) | Pharmaceutical unit | |
AU1103092A (en) | Immunopotentiating drug | |
AU2381392A (en) | Device for administering bimakalim transdermally | |
AU1676192A (en) | Multisubstituted 1-hydroxy-9-acridones with anticancer activity |